| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 411 |
| 1 | PREDNISONE | 273 |
| 2 | MYCOPHENOLATE MOFETIL | 227 |
| 3 | TACROLIMUS | 184 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 167 |
| 5 | TACROLIMUS OINTMENT 0.1% | 167 |
| 6 | CYCLOPHOSPHAMIDE | 101 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 101 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 101 |
| 9 | METHOTREXATE SODIUM | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOPHEDIANOL HYDROCHLORIDE, DEXCHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.1250 |
| 1 | FRANKINCENSE | 2 | 0.0328 |
| 2 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | 1 | 0.0189 |
| 3 | BACILLUS CALMETTE-GUERIN | 28 | 0.0157 |
| 4 | NIRSEVIMAB | 27 | 0.0151 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 45 | 0.0088 |
| 6 | STREPTOMYCIN | 5 | 0.0044 |
| 7 | TERBUTALINE SULFATE | 6 | 0.0033 |
| 8 | DILUENT | 3 | 0.0029 |
| 9 | TRIMIPRAMINE | 3 | 0.0027 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 30 | 0.0436 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 28 | 0.0157 |
| 2 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 27 | 0.0151 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 24 | 0.0041 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 46 | 0.0033 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 34 | 0.0026 |
| 6 | Human Immunoglobulin G [EPC] | 40 | 0.0019 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 516 | 0.0016 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 25 | 0.0012 |
| 9 | Endoglycosidase [EPC] | 2 | 0.0011 |